VALCARCE LOPEZ; Maria Carmen

Patent Applications and Registrations

Patent applications and USPTO patent grants for VALCARCE LOPEZ; Maria Carmen.The latest application filed is for "use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type i muscle fibers in an immobilized limb".

Company Profile

8.19.29

VALCARCE LOPEZ; Maria Carmen - Oak Ridge NC
Valcarce-Lopez; Maria Carmen - Limhamn SE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use Of A Ppar-delta Agonist For Reducing Loss Of Muscle Strength, Muscle Mass, Or Type I Muscle Fibers In An Immobilized Limb App 20220072005 - VALCARCE LOPEZ; Maria Carmen ; et al.	2022-03-10
Methods Of Treating Cognitive Impairment Or Improving Cognitive Function App 20210338639 - Valcarce Lopez; Maria Carmen	2021-11-04
Use of a PPAR-.delta. agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb Grant 11,096,946 - Valcarce Lopez , et al. August 24, 2	2021-08-24
Therapeutic Uses Of Glucokinase Activators In Combination With Insulin Or Insulin Analogs App 20210169857 - FREEMAN; Jennifer L.R. ; et al.	2021-06-10
Therapeutic Uses Of Glucokinase Activators In Combination With Insulin Or Insulin Analogs App 20210169858 - FREEMAN; Jennifer L.R. ; et al.	2021-06-10
Glucokinase activator compositions for the treatment of diabetes Grant 10,980,861 - Valcarce Lopez , et al. April 20, 2	2021-04-20
Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs Grant 10,952,993 - Freeman , et al. March 23, 2	2021-03-23
Therapeutic Uses Of Glp1r Agonists App 20210023072 - Freeman; Jennifer L.R. ; et al.	2021-01-28
Therapeutic Uses Of Glucokinase Activators In Combination With Insulin Or Insulin Analogs App 20200147052 - FREEMAN; Jennifer L.R. ; et al.	2020-05-14
Glucokinase Activator Compositions For The Treatment Of Diabetes App 20200138909 - Valcarce Lopez; Maria Carmen ; et al.	2020-05-07
Glucokinase activator compositions for the treatment of diabetes Grant 10,588,943 - Valcarce Lopez , et al.	2020-03-17
Use Of A Ppar-delta Agonist For Reducing Loss Of Muscle Strength, Muscle Mass, Or Type I Muscle Fibers In An Immobilized Limb App 20200046717 - VALCARCE LOPEZ; Maria Carmen ; et al.	2020-02-13
Use of a PPAR-.delta. agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb Grant 10,456,406 - Valcarce Lopez , et al. Oc	2019-10-29
Compositions comprising metformin and a glucokinase activator Grant 10,363,244 - Mjalli , et al.	2019-07-30
Treatment of Mild and Moderate Alzheimer's Disease App 20190142803 - Orlandi; Cesare ; et al.	2019-05-16
Compositions Comprising Metformin and A Glucokinase Activator App 20180344706 - Mjalli; Adnan M.M. ; et al.	2018-12-06
Glucokinase Activator Compositions for the Treatment of Diabetes App 20180311314 - Valcarce Lopez; Maria Carmen ; et al.	2018-11-01
Use Of A Ppar-delta Agonist For Reducing Loss Of Muscle Strength, Muscle Mass, Or Type I Muscle Fibers In An Immobilized Limb App 20180296562 - VALCARCE LOPEZ; Maria Carmen ; et al.	2018-10-18
Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator Grant 10,064,846 - Mjalli , et al. September 4, 2	2018-09-04
Glucokinase activator compositions for the treatment of diabetes Grant 10,004,782 - Valcarce Lopez , et al. June 26, 2	2018-06-26
Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb Grant 9,968,613 - Valcarce Lopez , et al. May 15, 2	2018-05-15
Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator Grant 9,855,251 - Mjalli , et al. January 2, 2	2018-01-02
Use of Metformin in Combination with a Glucokinase Activator and Compositions Comprising Metformin and a Glucokinase Activator App 20170354647 - Mjalli; Adnan M.M. ; et al.	2017-12-14
Treatment of Mild and Moderate Alzheimer's Disease App 20170326113 - Orlandi; Cesare ; et al.	2017-11-16
Treatment of mild and moderate Alzheimer's disease Grant 9,717,710 - Orlandi , et al. August 1, 2	2017-08-01
Use Of A Ppar-delta Agonist For Reducing Loss Of Muscle Strength, Muscle Mass, Or Type I Muscle Fibers In An Immobilized Limb App 20170027950 - Valcarce Lopez; Maria Carmen ; et al.	2017-02-02
Use of a PPAR-delta agonist for treating muscle atrophy Grant 9,487,493 - Valcarce Lopez , et al. November 8, 2	2016-11-08
Use of Metformin in Combination with a Glucokinase Activator and Compositions Comprising Metformin and a Glucokinase Activator App 20160184277 - Mjalli; Adnan M.M. ; et al.	2016-06-30
Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator Grant 9,359,313 - Mjalli , et al. June 7, 2	2016-06-07
Combinations of a GLP1R Agonist and Metformin and Use Thereof for the Treatment of Type 2 Diabetes and Other Disorders App 20150313908 - Mjalli; Adnan M.M. ; et al.	2015-11-05
Use Of A Ppar-delta Agonist For Treating Muscle Atrophy App 20150072985 - Valcarce Lopez; Maria Carmen ; et al.	2015-03-12
Heteroaryl-ureas and their use as glucokinase activators Grant RE45,183 - Murray , et al. October 7, 2	2014-10-07
Treatment of Mild and Moderate Alzheimer's Disease App 20140100218 - Orlandi; Cesare ; et al.	2014-04-10
Glucokinase Activator Compositions for the Treatment of Diabetes App 20140066372 - Valcarce Lopez; Maria Carmen ; et al.	2014-03-06
Heteroaryl-ureas and their use as glucokinase activators Grant 8,263,634 - Murray , et al. September 11, 2	2012-09-11
Use Of Metformin In Combination With A Glucokinase Activator And Compositions Comprising Metformin And A Glucokinase Activator App 20110313007 - Mjalli; Adnan M.M. ; et al.	2011-12-22
Aryl Carbonyl Derivatives As Therapeutic Agents App 20110301158 - Polisetti; Dharma Rao ; et al.	2011-12-08
Heteroaryl-ureas And Their Use As Glucokinase Activators App 20110060019 - Murray; Anthony ; et al.	2011-03-10
Heteroaryl-ureas and their use as glucokinase activators Grant 7,872,139 - Murray , et al. January 18, 2	2011-01-18
Heteroaryl-ureas and their use as glucokinase activators Grant 7,851,636 - Murray , et al. December 14, 2	2010-12-14
Heteroaryl-Ureas and Their Use as Glucokinase Activators App 20100204288 - Murray; Anthony ; et al.	2010-08-12
Heteroaryl-ureas and their use as glucokinase activators Grant 7,598,391 - Murray , et al. October 6, 2	2009-10-06
Heteroaryl-Ureas and Their Use as Glucokinase Activators App 20090216013 - Murray; Anthony ; et al.	2009-08-27
Aryl carbonyl derivatives as therapeutic agents App 20080119455 - Polisetti; Dharma Rao ; et al.	2008-05-22
Aryl carbonyl derivatives as therapeutic agents App 20080119454 - Polisetti; Dharma Rao ; et al.	2008-05-22
Heteroaryl-ureas and their use as glucokinase activators App 20070054897 - Murray; Anthony ; et al.	2007-03-08
Aryl carbonyl derivatives as therapeutic agents App 20040122235 - Polisetti, Dharma Rao ; et al.	2004-06-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.